Autolus Therapeutics Ltd. buy BiotechBee
Start price
21.12.22
/
60%
€1.77
Target price
31.12.24
€3.00
Performance (%)
26.55%
End price
24.06.23
€2.24
Summary
This prediction ended on 24.06.23 with a price of €2.24. The prediction had a final performance of 26.55%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Autolus Therapeutics Ltd. | - | - | - | - |
| iShares Core DAX® | -0.121% | 2.507% | 16.129% | 61.530% |
| iShares Nasdaq 100 | 0.081% | -0.241% | 4.636% | 97.770% |
| iShares Nikkei 225® | -1.748% | 4.105% | 16.103% | 48.713% |
| iShares S&P 500 | -0.961% | -0.143% | 1.644% | 62.430% |
According to BiotechBee what are the pros and cons of Autolus Therapeutics Ltd. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Autolus Therapeutics Ltd. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Autolus Therapeutics Ltd.
Buy beendet

